54 results
8-K
EX-99.1
LQDA
Liquidia Corp
1 Apr 24
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
7:00am
the injunction that was issued in August 2022 in the lawsuit filed by United Therapeutics (UTHR) in Case No. 1:20-cv-00755-RGA (the Original Hatch-Waxman … action, UTHR filed a lawsuit against FDA in the U.S. District Court for the District of Columbia (Case No. 24-484), and a motion for a temporary
8-K
LQDA
Liquidia Corp
1 Apr 24
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
7:00am
”).
In the first action, United Therapeutics filed a lawsuit against the FDA in the U.S. District Court for the District of Columbia (the “D.C. District … Bates, who is presiding over this lawsuit in the D.C. District Court, denied United Therapeutics’ motion. The D.C. District Court has scheduled a status
8-K
LQDA
Liquidia Corp
23 Jan 24
Other Events
7:30am
of the ‘793 Patent does not affect the injunction issued by District Court in the first Hatch-Waxman lawsuit filed by United Therapeutics in June 2020
8-K
EX-99.2
sau rbfugc9jr2cf
8 Jan 24
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
4:15pm
8-K
knetat8x4jgji2a33h
20 Dec 23
Other Events
5:16pm
8-K
EX-99.1
ktlbboxc be0n06w5x
20 Dec 23
Other Events
5:16pm
424B2
6h6iod4faqtswxdusvz
12 Dec 23
Prospectus for primary offering
4:41pm
8-K
EX-99.1
d1pxm6q8dz2kdxbd
7 Nov 23
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:36am
8-K
EX-99.1
ccj8cb21
6 Sep 23
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
4:37pm
8-K
EX-99.1
ez6bxbb sj52
19 Jul 22
Liquidia Receives Favorable Ruling in Inter Partes Review
5:27pm